Recalls & Warnings February 11, 2020 FTC Sues Two Companies Selling Bone Health and Joint Pain Supplements On February 11, 2020, the Federal Trade Commission (FTC) announced that it sued two companies to stop them from continuing to make false claims about their bone and joint health products, Ostinol (ZyCal Bioceuticals) and StimTein (Excellent Marketing Results, Inc
During the keto boom, a lot of brands launched cookies, bars, powders, snacks, and supplements that were built for a very specific moment
Done right, it can be incredibly convincingthe key is to keep the overlining subtle to avoid an unnatural look
Tirzepatide represents a new generation of dual-target GLP-1/GIP drugs, ofering a new treatment option for patients with type 2 diabetes and obesity
This includes optimizing study designs, managing compliance with regulatory standards like GLPs, and ensuring timely data collection and analysis